The University Hospital Llandough, in Penarth, south Wales was forced to delay 81 operations after thieves snatched copper cabling from the unit near Cardiff.

The thieves left vital back-up generator out of order after they stole copper cabling from it. Health chief condemned the theft as ‘absolutely disgraceful’. The generator could require as much as £20,000 to repair while the stolen wire could be only worth about a few hundred pounds as scrap.

MPs in the UK have warned that financial considerations will result in a major re-organization in the NHS services in England.

It has been reported that the quarterly net profits of Apollo Hospital Enterprises have increased by 31% for the year 2011. The enterprise booked a commendable profit through its outstanding sales of 6.48 billion rupees. Moreover, the total income of the Company rose to Rs 641.01 crore for the quarter ended June 30, 2011 as against Rs 523.29 crore for the corresponding period last fiscal.

Recently there was an announcement made by the Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS) that it has made an agreement with Abu Dhabi Health Services Co. PJSC (SEHA) with intention to handle the management of its dialysis facilities in the emirate of Abu Dhabi.  

It is the world’s largest provider of dialysis products and services, while SEHA is a public provider of health care services in the United Arab Emirates.

Technical analyst Kunal Saraogi is bullish on Fortis Healthcare (India) Limited and has maintained 'buy' rating on the stock with a target of Rs 175-180.

Mr. Saraogi said that the investors can buy the stock above Rs 154.

The stock of the company, on March 24, ended at Rs 150.20 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 185.70 and a low of Rs 129 on BSE.

Current EPS & P/E ratio stood at 3.01 and 49.83 respectively.

The Pakistan Ministry of Health has clearly laid down a policy to guide the provinces in effectively managing the polio immunization drive!

Going by the guidelines given by the Ministry of Heath, the provinces have been asked to effectively run awareness campaigns for making the parents aware of the need to get anti-polio drops administered to their children --- more so as it is basically the children who face the maximum risk of being hit by the highly infectious viral disease.

According to the experts, India has the world’s one-fourth cervical cancer patients. It is an alarming situation for any country. India should start public awareness campaign programs. These should be implemented aggressively in the public education.

Cervical cancer is the most frequent and dangerous cancer which affect women in India. Statistic records claim that around 366 million women are affected by cancer. This includes children from the age of 15 and older. The global figures are over 530,000 in one year. Among it, India alone contributes 134,000.

Every year, almost 73,000 women die of cancer disease. The projected statistical count of cancer patients by 2025 is 204,000. The deaths expected are 115,000.

Saturday was distinguished as ‘Misery Day’ by the doctors across the city. This was done because the doctors were not happy with the tax hike of 5 percent on healthcare in the recent health budget. They have shown their disapproval and gathered near the Governor’s house showing their discontent.

Dr. Devi Shetty, a city based cardiologist, has stated that a patient who operated for a heart surgery will have to pay Rs.5, 000 to Rs.10, 000 more with the introduction of the proposed service tax.  And the tax for the cancer patients for their operation will be more than 20000.

Health insurance policy holders can switch companies from July 1 this year. Previously they have fear of losing benefits of a `no claim' record or apprehensions that they may have to wait before certain health conditions are covered.

It is proposed by the insurance regulator (IRDA) that insurers must allow policyholders to transfer the credit in terms of waiting period for pre-existing illness and bonus sum insured from one insurer to another.

Fortis healthcare, the second largest hospital chain in India is said to be evaluating a plan wherein they are going to transfer all the land assets to a real estate investment trust (REIT). The money thus obtained is going to be used for the purpose of expansion.

Technical analyst Kunal Saraogi has maintained 'buy' rating on Fortis Healthcare Limited stock with a target of Rs 145.

According to analyst, the stock can be purchased with a stop loss of Rs 132.

The stock of the company, on February 01, closed at Rs 134.35 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 129 on BSE.

Current EPS & P/E ratio stood at 2.70 and 51.34 respectively.

Hospitals have to pay a fine of £250 per patient per day for breaking rules on mixed-sex accommodation. There were around 11,000 breaches in last one month.

The Government has revealed this fact in its recent statement and it has also informed that Yorkshire has seen the lowest number of breaches.

Andrew Lansley the Health Secretary has exposed a data of about 11,362 patients who were put in to the accommodation of mixed-sex during this December.

Shares of makers of hip and knee replacements, Smith & Nephew Plc saw a rise which was highest in the last six years. The price rise was propelled by rumors that it had refused a 7 billion-pound ($10.9 billion) takeover offer made by Johnson & Johnson.

The offer was said to have been made somewhere close to Christmas. No comments on the same were made by David Illingworth, Smith & Nephew's chief executive officer. He, however, did comment on an occasion where he did say that such speculations had been going in for the last 10 years.

Fortis Healthcare pronounced its foray into Speciality Medical Centres, which will further concentrate on the cure of metabolic diseases, comprising of diabetes and hormonal disorders.

These standalone centres will aid in expansion of Fortis's reach and capacity to attain the increased demands for quality healthcare services, Fortis Healthcare explained through a statement.

An all new vaccine has been put against meningitis B that apparently will be scheduled for the next year with Novartis claiming that the shot has been tested in case of human beings.

Novartis’ drug, Bexsero has been bestowed by health experts who state that the jab will aid in a sharp decline in the number of children death due to the disease.

The NHS trust, which is running based on Queen Alexandra Hospital, is aimed towards closure in the financial year with a deficit of £8m.

Bosses state that despite the fact of generation of million pounds' worth of savings – which comprises of 500 staff – are still kept in red.

The financial condition is such that the trust might have to hand over the cap to regional health bosses for an emergency loan in order to ensure to pay the bill amount.

Michael McGimpsey has supported the thoughts of a senior health official's over the fact that nearly 4,000 jobs would be cut in heath department if Stormont's draft budget is approved.

Regional Health and Social Care Board chief executive, John Compton, said waiting times might as well get stretched too.

It was further pronounced on Wednesday the health budget would increase by £326m.

But the health minister assured that Mr Compton's comment might prove to be of "several million pounds short".

Technical analyst Rajesh Tambe of Sunchan Securities has maintained 'hold' rating on Fortis Healthcare Limited stock to achieve a long term target.

The analyst said that the stock can be purchased with a target of Rs 250.

Today, the stock of the company opened at Rs 148.80 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 113 on BSE.

Current EPS & P/E ratio stood at 2.70 and 55.35 respectively.

The Serum Institute is looking to bringing MenAfricVac to India, the conjugate vaccine for meningitis it has made for Africa. Researchers and scientists say that the vaccine will give protection for more duration to infants than the polysaccharide vaccines made use of currently apart from inducing herd immunity.

Technical analyst Anil Singhvi is bullish on Fortis Healthcare Ltd and has recommended 'buy' rating on the stock with a target of Rs 200.

According to analyst, the interested investors can buy the stock with a stop loss of Rs 150.

Mr. Singhvi added that the investors can achieve the said target within a period of 30-45 days.

The stock of the company, on Nov 22, closed at Rs 152.15 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 104 on BSE.